Ohio State University spinout Entrada Therapeutics has pocketed $116m in a series B round.

MD Anderson Cancer Center spinout OncoResponse has added $40.6m to its coffers thanks to series C investors including Arch Venture Partners.

Susquehanna Growth Equity has returned to back the Citi and PNG-backed accounting software provider’s latest round, which was raised at a $3.1bn valuation.

The Coinbase, Samsung, Animoca Brands, Alphabet, Endeavor and Axiomatic-backed virtual trading card manager is reportedly now valued at $2.6bn.

SIG China has returned to back a series D2 round for the inner-city logistics services provider, which also counts Hearst and Beijing Hualian Group as investors.

Cash Capital has returned for OnQuality Pharmaceuticals’s latest round, having already participated in a $15m series A in 2019.

Satt Paris-Saclay’s portfolio company Altaroad has raised $11.7m in funding.

Existing backers Lilly Asia Ventures and Osage University Partners helped the UCSF cancer therapy spinout close its series A round.

Existing backers Lilly Asia Ventures and Osage University Partners helped the UCSF cancer therapy spinout close its series A round.

The BCC, Naspers and Tencent-backed educational services provider secured the funding in a tranche of its series F round, valuing it at over $13bn.